Steven Mintz - 12 Sep 2024 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 Sep 2024, 18:53:39 UTC
Prior SEC filing
19 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Steven Mintz
Filing notes and source

Key filing fact

Steven Mintz filed Form 4 for Serina Therapeutics, Inc. (SER) on 16 Sep 2024.

Key facts

  • This page summarizes Steven Mintz's Form 4 filing for Serina Therapeutics, Inc. (SER).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Sep 2024, 18:53.

Change

  • Previous filing in this sequence was filed on 19 Aug 2024.
  • Current net transaction value: +$38,814.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SER transaction

Common Stock

Purchase

Transaction value
$38,814
Shares
+6,000
Change %
+52%
Price
$6.47
Shares after
17,443
Date
12 Sep 2024
Ownership
By Spouse
Footnotes
F1
SER holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
12,257
Date
12 Sep 2024
Ownership
Direct
SER holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,040
Date
12 Sep 2024
Ownership
By Adult Child 1
Footnotes
F2
SER holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,840
Date
12 Sep 2024
Ownership
By Adult Child 2
Footnotes
F3
SER holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,650
Date
12 Sep 2024
Ownership
By Adult Child 3
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The price reflects the weighted average purchase price of multiple transactions. Upon the written request of the SEC, the issuer or a security holder of the issuer, the Reporting Person agrees to provide the number of shares sold at each sale price.

Footnote F2

The Reporting Person may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.

Footnote F3

The Reporting Person may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.

Footnote F4

The Reporting Person may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .